Ligand ID: BRL

Drugbank ID:
Rosiglitazone
(DB00412)

Indication:
Rosiglitazone is a thiazolidinedione indicated as an adjunct to diet and exercise to maintain glycemic control in type 2 diabetes.

LIST OF BINDING INTERFACES for query 'BRL'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
(Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details
7AWC_A_BRLA501	7awc	BRL	Rosiglitazone (DB00412)	Homo sapiens	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA	Hormone_recep	22	ILE A 281 PHE A 282 GLY A 284 CYS A 285 GLN A 286 ARG A 288 SER A 289 HIS A 323 ILE A 326 TYR A 327 LEU A 330 VAL A 339 LEU A 340 ILE A 341 MET A 348 LEU A 353 PHE A 363 MET A 364 HIS A 449 LEU A 453 LEU A 469 TYR A 473	BRL A 501		Details
DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details

[["7AWC_A_BRLA501","7awc","BRL","Rosiglitazone (DB00412)","Homo sapiens","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","Hormone_recep",22,"ILE A 281;PHE A 282;GLY A 284;CYS A 285;GLN A 286;ARG A 288;SER A 289;HIS A 323;ILE A 326;TYR A 327;LEU A 330;VAL A 339;LEU A 340;ILE A 341;MET A 348;LEU A 353;PHE A 363;MET A 364;HIS A 449;LEU A 453;LEU A 469;TYR A 473","BRL A 501\r"]]